Blueshift Asset Management LLC Takes Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Blueshift Asset Management LLC purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 15,880 shares of the company’s stock, valued at approximately $630,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP grew its holdings in shares of Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after buying an additional 454,044 shares during the period. State Street Corp lifted its position in Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after acquiring an additional 95,613 shares in the last quarter. Point72 Asset Management L.P. lifted its position in Acadia Healthcare by 0.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock valued at $144,753,000 after acquiring an additional 12,470 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in Acadia Healthcare by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after acquiring an additional 14,197 shares in the last quarter.

Acadia Healthcare Stock Down 0.9 %

Shares of ACHC stock opened at $29.01 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm’s 50-day moving average is $38.88 and its 200-day moving average is $47.32. The stock has a market cap of $2.70 billion, a price-to-earnings ratio of 9.51, a PEG ratio of 1.46 and a beta of 1.38. Acadia Healthcare Company, Inc. has a 52-week low of $27.61 and a 52-week high of $82.41.

Wall Street Analyst Weigh In

ACHC has been the topic of several research reports. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $43.00 to $35.00 in a research report on Friday, February 28th. Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. KeyCorp cut their price objective on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, March 3rd. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Finally, TD Cowen cut their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $56.31.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.